|
VERV Verve Therapeutics Inc 1840574 |
| Balance Sheet |
|
Current Assets
|
542,751,000 |
|
Assets
|
647,392,000 |
|
Current Liabilities
|
42,909,000 |
|
Liabilities
|
153,992,000 |
|
Equity
|
493,400,000 |
|
Shares Out
|
84,625,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-157,692,000 |
|
Investing Cash Flow
|
74,876,000 |
| Market Analysis |
Market Cap
|
463,742,426 |
|
Price
|
5.72 |
|
BVPS
|
5.83 |
|
PB
|
0.99 |
|
EPS
|
-2.59 |
|
PS
|
3.15 |
|
FCF
|
-82,816,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VERV documents filed with the SEC.
VERV Filings
Clear
